With respect I would think that if the results are really successful and they subsequently partner up with a tier one pharma then .40c is low. We are looking at a runway of a decade or more with two more goodies in the pipeline that could actually be much better revenue generators than that of the current offering. This is certainly true in that if the current is successful then that in many ways derisks Fragile X which, oh by the way, is a much larger market opportunity to be sure. Fingers crossed and yes, for the kids and amazing parents, I truly hope this happens for them.
GLTA!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.54 |
Change
0.100(0.80%) |
Mkt cap ! $1.559B | |||
| Open | High | Low | Value | Volume |
| $12.44 | $12.73 | $12.13 | $11.07M | 885.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1215 | $12.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.54 | 804 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |